Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Production and Supply of α-Particle-Emitting Radionuclides for Targeted α-Therapy.
Radchenko V, Morgenstern A, Jalilian AR, Ramogida CF, Cutler C, Duchemin C, Hoehr C, Haddad F, Bruchertseifer F, Gausemel H, Yang H, Osso JA, Washiyama K, Czerwinski K, Leufgen K, Pruszyński M, Valzdorf O, Causey P, Schaffer P, Perron R, Maxim S, Wilbur DS, Stora T, Li Y. Radchenko V, et al. Among authors: wilbur ds. J Nucl Med. 2021 Nov;62(11):1495-1503. doi: 10.2967/jnumed.120.261016. Epub 2021 Jul 22. J Nucl Med. 2021. PMID: 34301779 Free PMC article.
Biodistributions, myelosuppression, and toxicities in mice treated with an anti-CD45 antibody labeled with the alpha-emitting radionuclides bismuth-213 or astatine-211.
Nakamae H, Wilbur DS, Hamlin DK, Thakar MS, Santos EB, Fisher DR, Kenoyer AL, Pagel JM, Press OW, Storb R, Sandmaier BM. Nakamae H, et al. Among authors: wilbur ds. Cancer Res. 2009 Mar 15;69(6):2408-15. doi: 10.1158/0008-5472.CAN-08-4363. Epub 2009 Feb 24. Cancer Res. 2009. PMID: 19244101 Free PMC article.
α-Imaging Confirmed Efficient Targeting of CD45-Positive Cells After 211At-Radioimmunotherapy for Hematopoietic Cell Transplantation.
Frost SH, Miller BW, Bäck TA, Santos EB, Hamlin DK, Knoblaugh SE, Frayo SL, Kenoyer AL, Storb R, Press OW, Wilbur DS, Pagel JM, Sandmaier BM. Frost SH, et al. Among authors: wilbur ds. J Nucl Med. 2015 Nov;56(11):1766-73. doi: 10.2967/jnumed.115.162388. Epub 2015 Sep 3. J Nucl Med. 2015. PMID: 26338894 Free PMC article.
Bulk production and evaluation of high specific activity 186gRe for cancer therapy using enriched 186WO3 targets in a proton beam.
Mastren T, Radchenko V, Bach HT, Balkin ER, Birnbaum ER, Brugh M, Engle JW, Gott MD, Guthrie J, Hennkens HM, John KD, Ketring AR, Kuchuk M, Maassen JR, Naranjo CM, Nortier FM, Phelps TE, Jurisson SS, Wilbur DS, Fassbender ME. Mastren T, et al. Among authors: wilbur ds. Nucl Med Biol. 2017 Jun;49:24-29. doi: 10.1016/j.nucmedbio.2017.02.006. Epub 2017 Mar 3. Nucl Med Biol. 2017. PMID: 28288384
Evaluation of radioiodinated protein conjugates and their potential metabolites containing lysine-urea-glutamate (LuG), PEG and closo-decaborate(2-) as models for targeting astatine-211 to metastatic prostate cancer.
Li Y, Chyan MK, Hamlin DK, Nguyen H, Vessella R, Wilbur DS. Li Y, et al. Among authors: wilbur ds. Nucl Med Biol. 2021 Jan;92:217-227. doi: 10.1016/j.nucmedbio.2020.04.005. Epub 2020 May 3. Nucl Med Biol. 2021. PMID: 32409263 Free PMC article.
128 results